Healthcare provider profile · identity verified

Isia Atkinson, NP

Nurse Practitioner · LOUISVILLE, KY · NPI 1700505989

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	430	144
Amlodipine Besylate	Amlodipine Besylate	272	95
Losartan Potassium	Losartan Potassium	228	70
Gabapentin	Gabapentin	200	69
Albuterol Sulfate Hfa	Albuterol Sulfate	189	64
Rosuvastatin Calcium	Rosuvastatin Calcium	163	61
Metformin Hcl	Metformin Hcl	156	49
Omeprazole	Omeprazole	152	52
Chlorthalidone	Chlorthalidone	148	49
Lisinopril	Lisinopril	148	49
Furosemide	Furosemide	117	42
Trazodone Hcl	Trazodone Hcl	117	34
Pantoprazole Sodium	Pantoprazole Sodium	112	36
Hydrochlorothiazide	Hydrochlorothiazide	108	33
Metoprolol Succinate	Metoprolol Succinate	103	35
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	101	51
Carvedilol	Carvedilol	98	35
Montelukast Sodium	Montelukast Sodium	74	22
Potassium Chloride	Potassium Chloride	71	23
Fluticasone Propionate	Fluticasone Propionate	70	31
Levothyroxine Sodium	Levothyroxine Sodium	66	23
Pregabalin	Pregabalin	64	23
Sertraline Hcl	Sertraline Hcl	64	19
Farxiga	Dapagliflozin Propanediol	61	18
Duloxetine Hcl	Duloxetine Hcl	59	15
Ozempic	Semaglutide	59	16
Clonidine Hcl	Clonidine Hcl	57	18
Famotidine	Famotidine	54	17
Hydroxyzine Hcl	Hydroxyzine Hcl	54	25
Ibuprofen	Ibuprofen	52	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	47
Mounjaro	Tirzepatide	47	11
Glipizide	Glipizide	46	18
Metoprolol Tartrate	Metoprolol Tartrate	46	18
Prednisone	Prednisone	43	36
Simvastatin	Simvastatin	43	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	16
Spironolactone	Spironolactone	42	12
Tamsulosin Hcl	Tamsulosin Hcl	39	14
Jardiance	Empagliflozin	38	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Meloxicam	Meloxicam	37	15
Eliquis	Apixaban	36	17
Allopurinol	Allopurinol	34	16
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	18
Tramadol Hcl	Tramadol Hcl	33	19
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	22
Pravastatin Sodium	Pravastatin Sodium	28	11
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	24
Mirtazapine	Mirtazapine	26	suppressed
Trulicity	Dulaglutide	25	suppressed
Baclofen	Baclofen	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	13
Torsemide	Torsemide	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Linzess	Linaclotide	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	13
Alprazolam	Alprazolam	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Naproxen	Naproxen	20	suppressed
Nitroglycerin	Nitroglycerin	20	11
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Valsartan	Valsartan	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	14
Xarelto	Rivaroxaban	19	suppressed
Azithromycin	Azithromycin	18	18
Fluconazole	Fluconazole	18	16
Nifedipine Er	Nifedipine	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Latanoprost	Latanoprost	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	11
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Clonidine	Clonidine	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error